From: Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
ID | Pathway | Count | P-value | q-value |
---|---|---|---|---|
R-HSA-212436 | Generic transcription pathway | 15 | 0.000169248 | 0.01031453 |
WP3891 | Benzene metabolism | 2 | 0.000338181 | 0.01031453 |
R-HSA-73857 | RNA polymerase II transcription | 15 | 0.000564162 | 0.011471298 |
R-HSA-74160 | Gene expression (transcription) | 15 | 0.001668004 | 0.020896371 |
PA150642262 | Platinum pathway, Pharmacokinetics/pharmacodynamics | 2 | 0.001720726 | 0.020896371 |
R-HSA-156580 | Phase II—conjugation of compounds | 4 | 0.002055381 | 0.020896371 |
WP692 | Sulfation biotransformation reaction | 2 | 0.002963269 | 0.025340686 |
WP697 | Estrogen metabolism | 2 | 0.003323369 | 0.025340686 |
PWY-4061 | Glutathione-mediated detoxification | 2 | 0.005884846 | 0.035982304 |
R-HSA-156584 | Cytosolic sulfonation of small molecules | 2 | 0.006376838 | 0.035982304 |
path:hsa00983 | Drug metabolism—other enzymes—Homo sapiens (human) | 3 | 0.006488612 | 0.035982304 |